Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00773136|
Recruitment Status : Completed
First Posted : October 16, 2008
Results First Posted : April 16, 2014
Last Update Posted : April 16, 2014
- Study Details
- Tabular View
- Study Results
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Hypertrichosis||Drug: Bimatoprost Suspension||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||21 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Effect of Bimatoprost (Lumigan) in Gel Suspension Applied to the Eyelashes on Eyelash Growth|
|Study Start Date :||February 2008|
|Actual Primary Completion Date :||July 2008|
|Actual Study Completion Date :||July 2008|
Active Comparator: Bimatoprost Suspension
Intervention to be administered: Each subject was given two suspensions, one mixed with Bimatoprost and one mixed with normal saline. They were instructed to use each suspension to a pre-determined eyelash (prepared prior to study enrollment in double blind fashion and marked after randomization with right and left). The intervention was the one eye with the Bimatoprost.
Drug: Bimatoprost Suspension
Other Name: Lumigan
- Efficacy of Bimatoprost in Lengthening of Eyelashes [ Time Frame: 4.5 months (6 weeks of drug application and 3 months after discontinuing) ]Eyelash growth after application of bimatoprost vs control (split face study).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||20 Years to 90 Years (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- Age greater than 20 and less than 90 and patients who have previously used and are comfortable with applying mascara.
- History of glaucoma, uveitis, pregnancy, allergic reaction to prostaglandins or the gel suspension, alopecia, and previous usage of other eyelash growth enhancement.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00773136
|United States, Florida|
|University of Miami, Bascom Palmer Eye Institute|
|Miami, Florida, United States, 33136|
|Principal Investigator:||Wendy W Lee, MD||University of Miami|
|Responsible Party:||Sara T. Wester, Assistant Professor, University of Miami|
|Other Study ID Numbers:||
|First Posted:||October 16, 2008 Key Record Dates|
|Results First Posted:||April 16, 2014|
|Last Update Posted:||April 16, 2014|
|Last Verified:||March 2014|